SELP and head and neck squamous cell carcinoma: To study the efficacy of P-selectin-targeted PI3Kα inhibition in vivo, we selected one HNSCC cell line model (Cal-33) and one PDX model (H22) obtained from a patient with previously untreated advanced laryngeal cancer.